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Ui\IAIAR\' Eight children with acute leukemia in remission were jinm niz" I
witl\ live attenuated measles vaccine and 4 \\, ith mumps \, accine. Tmmuno-
logical examinations before \, accination showed that the numbers of white blood
cells, percentages of lymphocytes, levels of immunoglobulins and responses to skin
tests witlt DNCB, PPD, pHA and \, an cella antigen were within normal ran us in
most of these children. Chemotherapy against leukemia was stoppcd for 2 weeks,
from one week before to one week after vaccination. One child had a transient
fever 10 days after measles \, accination, but no side reactions weie observed in
the others, Seroconversion was observed in all but one child \\, ho received measles
vaccine, and neutralizing antibodies have persisted for at least 4 \\, ecks and at most
3 years, \\, hen this study \\, as tel'minated
INTRODUCTION
A{easles and mumps arc highly contagious
diseases in children and measles infection is
often severe or even fatal in children with
acute leukemia (A, litus at a1. , 1962; Pullan
at a1. , 1976; Young at a1. , 1980). Alumps
Is usualy mild in healtlty children but may
be complicated by meningitis or pancreatitis.
In our experience, unlike measles or varicella,
mumps infection usually causes similar clinical
reactions in Ieukemic children and healthy
children. But, there are some reports that
mumps Is severe in jinmunocompromised
children (Henson at a1. , 1971; Rashid at al. ,
1977). As children with acute leukemia now
tend to survive for. longer, prevention of their
infection with \, iruses has become very jin-
portant. So, \\, e administered live attenuated
measles and mumps vaccines to children \\, ith
acute leukemia under careful jinmunological
survey. The results obtained in this study
suggest that these vaccines are useful for jin-




The measles vaccine used was live further at-
tenuated " CAM 70 ", each dose of the vaccine
contained approximately 5 x 10' TclD, , of attenu-
ated measles virus. The mumps vaccine Lised was
live attenuated " BIKEN mumps vaccine , each
dose of the vaccine contained approximately I x
Volumes105 TclD, , of attenuated mumps virus.
of 0.5 inI of vaccine \\, ere Injected subcutaneously
into each child.
2. Uricci"ees and Docci, ,all'0, ,
Measles vaccine was administered to 7 children
with acute lymphocytic leukemia and one \\, ith acute
myelocytic leukemia. Mumps vaccine was admin-
is tored to 4 children with acute lymphocytic Ieuke-
All the children were attending our outpatient
clinic. They had been in a state of remission for
more than 4 months and had received anticancer
medication with 6-mercaptopurine (6MP) (2.0 to
3.0 ingjkglday ."ally) and mathotre*"te (30 inglm'
once a weel< intravenously) as maintenance therapy
and intermittent lntrathecal injection of methotr-
in Ia.
vincristine and steroid hormone as enforce.exate,
merit therapy. Administration of anticancer medi-
cation was suspended from one week before to one
week after vaccination in 5 children (case I-5, Table
I) \\, ith measles vaccine, but oral administration of
6MP was not suspended in the other children.
3. JINI, ,111,010gicn/ exa"if"all'o113 before uricci"anon
Before vaccination, hematological examination,
serum immunoglobulin estimation, and skin tests
with dinitrochlorobenzene (DNCB), purified pro-
tein derivative (FFD), phytohemagglutinin reHA)
and vancella virus antigen were done to determine
the jinmunological potential of tl\e children
4. Chill'cal obse, oatio, I andf0//o00 1111 $111dy
After vaccination, children were observed at
weekly intervals by physicians. Hematological ex-
aminations were also performed at weekly intervals.
Parents of the children were asked to record and
report the daily body temperature and any clinical
manifestations that might develope. When tlTese
were seen, physicians examined the children carefully.
In follow-up studies, all vaccinees received clinical
examinations in the outpatient clinic weel<Iy, and the




























































a I-8 = measles vaccinees, 9-12 = mumps vaccinees
' ALL : acute lymphocytic Ieul<emia, AML : acute myelocytic leukemia.
" DNCB : dinitrochlorobenzene, PPD : purified protein derivative, pHA : phytohemagglutinin.






























































































parents were asl{ed to report any contact \\, Ith cases
of nTeasles or mumps at home or school. Sera \\. ere
collected every fe\\. months and tested n. airily for
neutralizing antibod\. titers against measles and
nlurnps \, Iruses.
2. Airns/es "@cci"at1012
Table 2 shows the clinical reactions and
antibody responses after measles vaccination.
Only one child (case 8) had a fever of 38 C,
lasting I day, 10 days after \, accination.
There \\, ere no other adverse effects related
to \, accination or to suspension of anticancer
medication. No hematological changes \\, ere
detected in these vaccinees (data not shown).
Rise in measles antibody, \\, as detected in 7
of 8 \, accinees, the range of the titers being
I^2 to I^128. One child (.,^. 7) had ^
second bone marro\\, relapse 2 nTonths after
vaccination and contracted natural measles 6
I. 1111"INNologicdl States of adcci'?lees months after vaccination. Although he Ilad
The results of Immunological examinations no measles NT antibody, I month after vac-
before \, accination are shown in Table I cination, thc clinical course of measles was
Leukopenia (less than 3,000jinm3) \\, as ob- moderate. N'r antibodies \\, erc persistently
served in one child (case 3 ; 1,650) and a 10\\, detected for up to 3 months after vaccination
in one child and for up to 36 months in 2IgG level \\, as detected another child
(."^. 6 ; 445 ingldl). All th, children ^I. .wad children, and these children \\, CTe free from
two or more positive reactions in skin tests measles symptoms.
with DNCB, PPD, pHA and \, aricella antigen, we observed 3 cases of Ieukemic relapse
except one (casc I) who was tested only with among the measles vaccinces. Case I (All"L)
DNCB and FFD. The children who did relapsed 6 nTonths after vaccination and died
not respond to PPD or varicclla antigen gave 6 months later. Case 2 relapsed 10 months
TABLE 2. Cfimta/ 100cti'oils nild antibody, responses of child, 'err arith newte Jewhe, ,11'a to lit^e at-
Ie, INQted 711eos/es uriccZne
5. A1T rind H/ tesis
NICnsles neutralizing antibody titration (NT) and
hemagglutination inhibition (Hl) tests were done as
reported by Uedti (1971). The NT tests \\-as done
by the micro-method and the Hl tests by the ntncro-
method. itlumps netitralizing antibod\, titers \\ ere
measured by the Biken method, a nticro-metllod
(Yinnanisl, i at a1. , 1970).
RESULTS
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b when measles \\. as diagnosed















































































after vaccination and died 10 months later.
Case 7 had a second bone marrow relapse
2 months after vaccination and developed
natural measles infection 4 months later,
moderate.although his clinical course was
In this case, no measles NT antibody was
detected I month after vaccination. This
may be due to his depressed jinmunological










3 . MMn?s t, orci, tat, o11
The results of sequential NT antibody
shown in Table 3. Anexaminations are
was detected in all vac-antibody response
titer was 235The geometric meancinees.
No clini-(I: 11.3) 4 weeks after vaccination.








Hans. n at a1. (1971) and Rushid at a1. (1977)
suggested that mumps virus infection may
have a serious outcome in Tmmunocom-
promised children. The recent increase in
longevity of children with acute leukemia
and the more frequent use of jinmunosuppres-
sive agents for treatment of the disease have
increased the number of children with risk
of developing severe illness, though fortu-
nately few Ieukemic children are susceptible
to measles.
Mitus at a1. (1962) reported that application
of live measles vaccine to children with acute
leukemia was contraindicative. But, Izawa
at a1. (1977) reported that live vancella vaccine
was useful for prevention of vancella in
high-risk children with leukemia or other
malignancies, when applied under careful
hematological and jinmunological survey.
Nowadays, live measles vaccine has been
further attenuated and can be used more
widely than in the early 1960s in normal
children, and live mumps vaccine that does
not cause side effects is now commercially
available. Therefore, we applied live measles
and mumps vaccines to 8 and 4 children with
acute leukemia, respectively. Recently, one
of us proposed criteria for use of several live
virus vaccines in children with malignant
di^.,^.^ (Ihar, , 1981) (T^b1.4). \\,, an PIi. d
live vancella vaccine in 22 children with
acute leukemia, live attenuated measles vaccine
in 2 and live mumps vaccine in I according
to these criteria. Good responses were ob-
4 \\. k
Measles is severe in children with leukemia
(Alitus at a1. , 1962; Pullan at a1. , 1976; Yong
at a1. , 1980). But in our experience, unlike
measles or vancella, mumps infection usually
develops similarly in Ieukemic children and
healthy, children. In a nation wide survey
of infectious diseases in children witll acute
Ionk. min (K, inIy^, 1976), it w, ^ f. und that
varicella was the most severe and highly fatal
viral infection followed by measles, and that
mumps was not so severe. Among 46 children
with acute leukemia infected with measles,
8 had a severe course and 5 died, whereas
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TABLE 4. Grite, 'i0 101' uricci?rating childre, z
20ith acute Jewhe?, 11'a rind othei' "iai^^"anc, 'es
toith 12\!.!e Doccz'"e
I Status of disease
I) Complete remission of leukemia
2) Disease-free state of children with solid
malignant tumors
2 Tmmunological status
Positive skin reaction to DNCB and pHA
or PPD
3 High risk of natural Infection
4 Anticancer agents other than oral 6MP can
be suspended safely from one week before
to one \\. eel< after vaccination
tamed in most cases and there were Do severe
side effects (data not shown).
As mentioned above, 3 cases of leukemia
vaccinated with measles vaccine showed re-
lapse. However, we do not consider that
measles \, accination was responsible for these
relapses because tlTere was a long time be-
twcen vaccination and relapse and this was
different in each children. we obtained good
results with mumps vaccine in these patients,
and there were no serious problems. But
unfortunately, the number of vaccinated cases
was small and the observation period was only
3 months
In conclusion, although the number of \, ac-
cinated children was small, our results suggest
that live attenuated measles vaccination is not
contraindicativc in children \\, ith leukemia.
However, the vaccine must be administered
to children with acute leukemia with great
care, giving special consideration to jinmuno-
logical conditions. Live mumps vaccine is
safer and more effective than measles vaccine.
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